Should You Join Carl Icahn in Greenbrier?

ICAHN CAPITAL LPShares in The Greenbrier Companies (NYSE:GBX) rose about 15% on November 13th after billionaire Carl Icahn’s money management group reported that it had acquired 10% of the company’s shares outstanding, or 2.7 million shares. Icahn indicated that he was interested in exploring “strategic opportunities” for the manufacturer of railcars. His most recent 13F filing reported a steady position in American Railcar Industries, Inc. (NASDAQ:ARII); that company’s shares were up over 10% as the market speculated that Icahn may intend to push a merger between the two (something that he had actually pursued in 2008). Find more stocks that Icahn owns, including our take on the billionaire’s recent purchase of Netflix shares.

The railcar industry is tied to changes in the railroad industry, which in turn derives much of its business from the transportation of freight. The Greenbrier Companies therefore has a high beta of 3.3 which reflects how sensitive its business is to the broader economy. Looking at the company’s 10-K (Greenbrier has a fiscal year ending in August), revenue in the last fiscal year was more than double what it was in the fiscal year ending in August 2010; in that year, revenue had been down 41% from its level in the fiscal year ending in August 2008. Earnings show a cyclical pattern as well, with the company’s net income of about $120 million representing a large increase over the previous few years.

In terms of P/E multiples, The Greenbrier Companies is cheap- 8 times trailing earnings, with analyst consensus for 2013 placing it at 7 times forward earnings estimates- but we’ve seen that the business swings wildly with respect to economic conditions. The most recent data has 11% of the shares outstanding held short, and the stock is down 37% over the last year against a rising market. So there clearly was quite a bit of skepticism regarding the company’s prospects before Icahn bought in.

The closest peers for Greenbrier are American Railcar, which we’ve already mentioned is another Icahn pick, and railcar lessor GATX Corporation (NYSE:GMT). These companies trade at trailing P/E multiples in the 14-15 range, representing a substantial premium to Greenbrier. Wall Street analysts are much more bullish on American Railcar, with its forward P/E falling to 9 while GATX is expected to see very little growth. Both of these companies have standard December fiscal years and reported strong growth last quarter, with earnings up at least 60% from the third quarter of 2011. That is in keeping with the general increase in demand for railcars that also benefitted Greenbrier. As a result, we’d say that Greenbrier looks like a good pick for investors who want to take on the risk inherent in this business.

We can also look at railroads directly, such as Union Pacific Corporation (NYSE:UNP) and CSX Corporation (NYSE:CSX). The industry as a whole carries the Warren Buffett seal of approval as can be seen by Berkshire Hathaway’s purchase of Burlington Northern Santa Fe, and these two particular railroads have betas less than 1.5 and so offer less macro risk. They are also considerably larger companies, with CSX posting a market cap of about $20 billion and Union Pacific trading at almost three times that value. CSX’s business was about flat last quarter versus a year earlier while Union Pacific saw moderate earnings growth. Their respective earnings multiples reflect that CSX is a somewhat weaker business- its trailing P/E of 11 is a significant discount to Union Pacific- though with that company trading in the same range as American Railcar and GATX we’d say that either railroad looks like a better value than those two companies.

We think that an investor would be well served by going after the railroads directly unless they are very confident in U.S. macro and want as much exposure to railcar demand as possible. In that case, it’s a good idea to follow Icahn into Greenbrier as that company still looks undervalued compared to its peers.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!